123 related articles for article (PubMed ID: 28935847)
1. CD56
Kariminia A; Ivison S; Ng B; Rozmus J; Sung S; Varshney A; Aljurf M; Lachance S; Walker I; Toze C; Lipton J; Lee SJ; Szer J; Doocey R; Lewis I; Smith C; Chaudhri N; Levings MK; Broady R; Devins G; Szwajcer D; Foley R; Mostafavi S; Pavletic S; Wall DA; Couban S; Panzarella T; Schultz KR
Haematologica; 2017 Nov; 102(11):1936-1946. PubMed ID: 28935847
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic transplantation: peripheral blood vs. bone marrow.
Bensinger WI
Curr Opin Oncol; 2012 Mar; 24(2):191-6. PubMed ID: 22185938
[TBL] [Abstract][Full Text] [Related]
3. Long-term Outcomes of Peripheral Blood Stem Cell Unrelated Donors Mobilized with Filgrastim.
Stefanski HE; Kuxhausen M; Bo-Subait S; Kobusingye H; Mattila D; Schenfeld J; Sandschafer D; Burns LJ; Shaw BE; Pulsipher MA; Miller JP; Devine SM
Blood Adv; 2024 Apr; ():. PubMed ID: 38687368
[TBL] [Abstract][Full Text] [Related]
4. Amphiregulin as a biomarker for monitoring lifethreatening acute graft-
Holtan SG; El Jurdi N; Rashidi A; Betts BC; Demorest C; Galvin JP; MacMillan ML; Weisdorf DJ; Panoskaltsis-Mortari A; Pratta MA
Haematologica; 2024 May; 109(5):1557-1561. PubMed ID: 37706330
[No Abstract] [Full Text] [Related]
5. Spectral Flow Cytometry Methods and Pipelines for Comprehensive Immunoprofiling of Human Peripheral Blood and Bone Marrow.
Spasic M; Ogayo ER; Parsons AM; Mittendorf EA; van Galen P; McAllister SS
Cancer Res Commun; 2024 Mar; 4(3):895-910. PubMed ID: 38466569
[TBL] [Abstract][Full Text] [Related]
6. Unveiling amphiregulin: a blood-based biomarker for graft-
Choi SW
Haematologica; 2024 May; 109(5):1315-1316. PubMed ID: 37822241
[No Abstract] [Full Text] [Related]
7. Improving Outcomes in Chronic Graft-vs-Host Disease.
Mitchell SA; Cowen EW
JAMA Dermatol; 2024 Apr; 160(4):388-391. PubMed ID: 38416464
[No Abstract] [Full Text] [Related]
8. A milestone method to make natural killer T cells.
Metelitsa LS
Nat Biotechnol; 2024 May; ():. PubMed ID: 38744945
[No Abstract] [Full Text] [Related]
9. Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Connors JM; Jurczak W; Straus DJ; Ansell SM; Kim WS; Gallamini A; Younes A; Alekseev S; Illés Á; Picardi M; Lech-Maranda E; Oki Y; Feldman T; Smolewski P; Savage KJ; Bartlett NL; Walewski J; Chen R; Ramchandren R; Zinzani PL; Cunningham D; Rosta A; Josephson NC; Song E; Sachs J; Liu R; Jolin HA; Huebner D; Radford J;
N Engl J Med; 2018 Jan; 378(4):331-344. PubMed ID: 29224502
[TBL] [Abstract][Full Text] [Related]
10. Complex interactions of cellular players in chronic Graft-versus-Host Disease.
Gail LM; Schell KJ; Łacina P; Strobl J; Bolton SJ; Steinbakk Ulriksen E; Bogunia-Kubik K; Greinix H; Crossland RE; Inngjerdingen M; Stary G
Front Immunol; 2023; 14():1199422. PubMed ID: 37435079
[TBL] [Abstract][Full Text] [Related]
11. Chronic GvHD NIH Consensus Project Biology Task Force: evolving path to personalized treatment of chronic GvHD.
Buxbaum NP; Socié G; Hill GR; MacDonald KPA; Tkachev V; Teshima T; Lee SJ; Ritz J; Sarantopoulos S; Luznik L; Zeng D; Paczesny S; Martin PJ; Pavletic SZ; Schultz KR; Blazar BR
Blood Adv; 2023 Sep; 7(17):4886-4902. PubMed ID: 36322878
[TBL] [Abstract][Full Text] [Related]
12. A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study.
Cuvelier GDE; Ng B; Abdossamadi S; Nemecek ER; Melton A; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savaşan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; Ostroumov E; Schultz KR
Blood Adv; 2023 Jul; 7(14):3612-3623. PubMed ID: 36219586
[TBL] [Abstract][Full Text] [Related]
13. CD56bright CD16- natural killer cells as an important regulatory mechanism in chronic graft-
Lauener M; AzadPour S; Abdossamadi S; Parthasarathy V; Ng B; Ostroumov E; Cuvelier GDE; Levings MK; MacDonald KN; Kariminia A; Schultz KR
Haematologica; 2023 Mar; 108(3):761-771. PubMed ID: 36200416
[TBL] [Abstract][Full Text] [Related]
14. Harnessing Mechanisms of Immune Tolerance to Improve Outcomes in Solid Organ Transplantation: A Review.
Slepicka PF; Yazdanifar M; Bertaina A
Front Immunol; 2021; 12():688460. PubMed ID: 34177941
[TBL] [Abstract][Full Text] [Related]
15. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report.
Pidala J; Kitko C; Lee SJ; Carpenter P; Cuvelier GDE; Holtan S; Flowers ME; Cutler C; Jagasia M; Gooley T; Palmer J; Randolph T; Levine JE; Ayuk F; Dignan F; Schoemans H; Tkaczyk E; Farhadfar N; Lawitschka A; Schultz KR; Martin PJ; Sarantopoulos S; Inamoto Y; Socie G; Wolff D; Blazar B; Greinix H; Paczesny S; Pavletic S; Hill G
Transplant Cell Ther; 2021 Aug; 27(8):632-641. PubMed ID: 33836313
[TBL] [Abstract][Full Text] [Related]
16. "Age Related Differences in the Biology of Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation".
Cuvelier GDE; Li A; Drissler S; Kariminia A; Abdossamadi S; Rozmus J; Chanoine JP; Ng B; Mostafavi S; Brinkman RR; Schultz KR
Front Immunol; 2020; 11():571884. PubMed ID: 33193355
[TBL] [Abstract][Full Text] [Related]
17. Should we use extracorporeal photopheresis more often? Evidence from graft-versus-host disease patients monitored with Treg as a biomarker.
Lopes SM; Roncon S; Pinho AC; Bordalo F; Antunes L; Campilho F; Campos A; Costa-Pereira A
Future Sci OA; 2020 Aug; 6(8):FSO623. PubMed ID: 32983569
[TBL] [Abstract][Full Text] [Related]
18. Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies.
Schultz KR; Kariminia A; Ng B; Abdossamadi S; Lauener M; Nemecek ER; Wahlstrom JT; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Flower A; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savasan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; Azadpour S; Ostroumov E; Subrt P; Halevy A; Mostafavi S; Cuvelier GDE
Blood; 2020 Apr; 135(15):1287-1298. PubMed ID: 32047896
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
